2021
Snowball Sampling Study Design for Serosurveys Early in Disease Outbreaks
Kennedy-Shaffer L, Qiu X, Hanage W. Snowball Sampling Study Design for Serosurveys Early in Disease Outbreaks. American Journal Of Epidemiology 2021, 190: 1918-1927. PMID: 33831177, PMCID: PMC8083564, DOI: 10.1093/aje/kwab098.Peer-Reviewed Original Research
2017
Infections from seven clinical trials of ixekizumab, an anti‐interleukin‐17A monoclonal antibody, in patients with moderate‐to‐severe psoriasis
Papp K, Bachelez H, Blauvelt A, Winthrop K, Romiti R, Ohtsuki M, Acharya N, Braun D, Mallbris L, Zhao F, Xu W, Walls C, Strober B. Infections from seven clinical trials of ixekizumab, an anti‐interleukin‐17A monoclonal antibody, in patients with moderate‐to‐severe psoriasis. British Journal Of Dermatology 2017, 177: 1537-1551. PMID: 28600810, DOI: 10.1111/bjd.15723.Peer-Reviewed Original ResearchConceptsIncidence rateTreatment groupsInfection rateSpecific infection rateSevere psoriasisSerious infectionsExposure-adjusted incidence ratesIRs of infectionsMonoclonal antibodiesWeeks of treatmentOverall infection rateIncidence of infectionOesophageal candidiasisBiological therapyPsoriasis trialsAntifungal therapyClinical trialsIxekizumabCandida infectionsPatientsLong-term exposureInfectionPsoriasisIncidenceTrials
2008
Routine Use of Wound Vacuum-Assisted Closure Does Not Allow Coverage Delay for Open Tibia Fractures
Bhattacharyya T, Mehta P, Smith M, Pomahac B. Routine Use of Wound Vacuum-Assisted Closure Does Not Allow Coverage Delay for Open Tibia Fractures. Plastic & Reconstructive Surgery 2008, 121: 1263-1266. PMID: 18349645, DOI: 10.1097/01.prs.0000305536.09242.a6.Peer-Reviewed Original ResearchConceptsOpen tibia fracturesVacuum-assisted closureSoft tissue coverageTibia fracturesInfection rateRoutine useGrade IIIB open fracturesOpen fracturesVacuum-assisted closure therapyVacuum-assisted closure deviceOpen fracture woundsOverall infection ratePrevention of infectionRate of infectionGreater mean timeType of fixationSurgical debridementFracture woundsTrauma registryClosure therapyFlap coverageInfected patientsMedical recordsClosure devicePositive cultures
1988
A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb
Dardik H, Miller N, Dardik A, Ibrahim I, Sussman B, Berry S, Wolodiger F, Kahn M, Dardik I. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. Journal Of Vascular Surgery 1988, 7: 336-346. DOI: 10.1016/0741-5214(88)90153-x.Peer-Reviewed Original ResearchConceptsGraft failureHuman umbilical cord vein graftAdjunctive distal arteriovenous fistulasCumulative graft patency rateSuccessful graft replacementGraft patency rateLower limb bypassOverall clinical impactDistal arteriovenous fistulaLimited life expectancyOverall infection rateSitu saphenous veinKnee poplitealPopliteal reconstructionAnastomotic aneurysmsFoot gangreneGraft aneurysmGraft thrombosisGraft replacementDistal anastomosisPeroneal bypassVein graftsGraft dilationPatency ratesArteriovenous fistulaA decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb.
Dardik H, Miller N, Dardik A, Ibrahim I, Sussman B, Berry S, Wolodiger F, Kahn M, Dardik I. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. Journal Of Vascular Surgery 1988, 7: 336-46. PMID: 3123718, DOI: 10.1067/mva.1988.avs0070336.Peer-Reviewed Original ResearchConceptsGraft failureHuman umbilical cord vein graftAdjunctive distal arteriovenous fistulasCumulative graft patency rateSuccessful graft replacementGraft patency rateLower limb bypassOverall clinical impactDistal arteriovenous fistulaLimited life expectancyOverall infection rateSitu saphenous veinKnee poplitealPopliteal reconstructionAnastomotic aneurysmsFoot gangreneGraft aneurysmGraft thrombosisGraft dilatationGraft replacementDistal anastomosisPeroneal bypassVein graftsPatency ratesArteriovenous fistula
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply